Tom Civik joined Foundation Medicine in November 2017 as the Company’s chief commercial officer. As an accomplished commercial leader, Mr. Civik possesses a proven track record delivering strong commercial results, launching blockbuster and targeted therapies, and leading large sales, marketing and market access teams.
Mr. Civik built a distinguished career spanning 17 years in Genentech’s commercial organization. Most recently, Mr. Civik was a vice president and officer at Genentech, responsible for leading commercialization efforts for several leading oncology products delivering more than $3 billion in revenue. Prior to joining the oncology team at Genentech, Mr. Civik led the commercial activities for a portfolio of products focused on stroke and cardiovascular disease. Mr. Civik began is his career at Genentech in the managed care area, holding increasingly complex roles focused on delivering access for the entire Genentech portfolio. Prior to Genentech, Mr. Civik spent eight years at Sanofi where he held increasing complex roles in sales, sales management and account management.
Mr. Civik received a Bachelor of Arts degree from the Saint Norbert College and a Master's degree in business administration from the Kellogg School of Management at Northwestern University.